Ergothioneine

Ergothioneine is a 6.5–7.0/10 fit for the longevity-minded person who eats few mushrooms and wants a cheap, very safe, tissue-retained antioxidant while the human outcome trials catch up to the biology. The case rests on an exceptional mechanism and the Smith et al. 2020 cohort, where higher plasma levels tracked with 21% lower cardiovascular mortality over two decades, balanced against the honest reality that only two small interventional trials exist and one was industry-funded. That makes ergothioneine a sensible long-game hedge for a defined reader, and a poor choice for anyone expecting a felt effect or treating it as a substitute for proven care. In practice it belongs after the basics, alongside a mushroom-rich diet, with your own lipids and inflammation tracked so you judge it by your numbers rather than the hype.

✅ Best for: Adults over 60, whose blood ergothioneine has naturally declined, who want a low-risk antioxidant hedge. People who rarely eat mushrooms and therefore run low on dietary intake. Longevity enthusiasts who want a cheap, very safe foundational nutrient with a genuine transporter-backed mechanism. Anyone with a strong family history of cardiovascular disease who is already doing the established things and wants a well-tolerated adjunct they can track. Pragmatic biohackers comfortable making a plausible long-game bet on strong biology while honestly acknowledging the interventional evidence is still maturing.

❌ Avoid if: You are pregnant or breastfeeding, since supplement-dose safety is not established, though dietary mushrooms are fine. You expect a noticeable acute or short-term effect, because there is none. You would use it in place of proven cardiovascular or cognitive care, which the association data in Smith et al. 2020 does not support. You already eat mushrooms several times a week and likely carry ample stores. You have a known mushroom allergy and are considering mushroom-extract sources rather than purified fermentation-derived material.